Hepatocellular Carcinoma in the Pediatric Population: A Population Based Clinical Outcomes Study Involving 257 Patients from the Surveillance, Epidemiology, and End Result (SEER) Database (1973–2011)
Table 1
Demographic profiles of 63,514 adults and 257 pediatric patients with hepatocellular carcinoma from the Surveillance, Epidemiology, and End Results (SEER) database, 1973–2011.
Variables
Overall
Pediatric patients
Adult patients
value
(%)
63,771
257 (0.4%)
63,514 (99.6%)
—
Age, (Mean ± SD)
64 ± 13
13 ± 5
64 ± 12
<0.001
Mean overall survival (years)
2.833 ± 0.076
7.988 ± 0.845
2.781 ± 0.075
<0.001
Gender, (%)
Male
47,862 (75.1%)
153 (59.5%)
47,709 (75.1%)
<0.001
Female
15,909 (24.9%)
104 (40.5%)
15,805 (24.9%)
<0.001
Race, (%)
Caucasian
32,130 (50.5%)
128 (50.4%)
32,002 (50.5%)
0.03
African American
7,829 (12.3%)
29 (11.4%)
7,800 (12.3%)
0.02
Hispanic
10,285 (16.2%)
49 (19.3%)
10,239 (16.2%)
0.03
Asian/Pacific Islander/Native Americans
13,347 (21.0%)
48 (18.9%)
13,299 (21.0%)
0.03
= number; SD = standard deviation; data presented for patients with available information only.
